Logan Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-66
Closed -$12 494
2023
Q2
$12 Hold
66
﹤0.01% 485
2023
Q1
$105 Hold
66
﹤0.01% 490
2022
Q4
$129 Sell
66
-136
-67% -$335 ﹤0.01% 517
2022
Q3
$1K Hold
202
﹤0.01% 496
2022
Q2
$1K Sell
202
-1
-0.5% -$6 ﹤0.01% 526
2022
Q1
$2K Hold
203
﹤0.01% 515
2021
Q4
$4K Hold
203
﹤0.01% 511
2021
Q3
$7K Hold
203
﹤0.01% 474
2021
Q2
$8K Hold
203
﹤0.01% 463
2021
Q1
$13K Buy
+203
New +$14.2K ﹤0.01% 423

Other funds holding SRGA

Logan Capital Management's SRGA Position: Q3 2023 in Review

Logan Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 66 shares — an estimated $12 sold.

Logan Capital Management first reported a position in SRGA in Q1 2021 and held it in 10 quarters. The position peaked at $13K in Q1 2021. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

  • Logan Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Logan Capital Management sold 66 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $12.
  • Logan Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Logan Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $13K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on Logan Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.